One-Fifth of Bulgarians Believe COVID-19 Threat was Exaggerated
Data from a recent global poll conducted by the world association "Gallup International" represent the diverse perceptions surrounding the threat posed by the coronavirus pandemic
New Russian COVID-19 Vaccine is Scheduled to Start the Phase 3 Trials Next Week in Russia
- Tweet
Send to Kindle
pixabay.com
Russia, which has reported more than 822,000 cases of COVID-19 and is currently the world’s fourth most COVID-infested country, has concluded plans to register a coronavirus vaccine between August 10 and August 12 this year.
This will make way for what will be regarded as the world’s first official approval of a vaccine against the COVID-19 pandemic.
According to a report by Bloomberg, the vaccine is being developed by Russia’s Gamaleya Institute and the Russian Direct Investment Fund. Approval for human use is expected to be within 3 to 7 days after registration by regulators.
Back story: Two weeks ago, Nairametrics had reported that the head of the Russian wealth fund (RDIF) hinted that Russia could make available a vaccine for the treatment of Coronavirus as early as September. He said that a deal had been agreed with AstraZeneca to manufacture a COVID-19 vaccine being developed by the pharmaceutical giant and Oxford University.
This new Russian vaccine, which is scheduled to start the Phase 3 trials next week in Russia, Saudi Arabia, and the United Arab Emirates, has been adjudged safe and will potentially become the first to reach the public.
The head of RDIF, Kirill Dmitrev, said in an interview with CNN that “Americans were surprised when they heard sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first.’’
The Health Minister, Mikhail Murashko, had also disclosed that the Russian vaccine would first be made available to health professionals before clinical trials are completed.
Research institutes and pharmaceutical companies in countries like the U.S., the U.K., Japan, and China are also in the race to develop vaccines. AstraZeneca Plc, Moderna Inc. and Pfizer Inc. have all started late-stage testing for Covid-19 vaccines, with initial results from some of the human trials expected as early as October. Phase 3 tests typically take months to run in order to better understand a drug’s effectiveness.
The race to develop a vaccine for Coronavirus, which has already exceeded 16.7 million cases globally with over 660,000 deaths, has recently been intensified. The UK who just secured another 60 million doses of Sanofi/GSK COVID-19 vaccine, now has most vaccine doses per capita, ahead of US. / nairametrics.com
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
First Measles Case Reported in Bulgaria!
The National Center for Infectious and Parasitic Diseases in Bulgaria has confirmed the country's first case of measles, sparking concerns about potential outbreaks.
Bulgaria Faces Critical Shortage: Over 30,000 Nurses Needed Nationwide
While assurances of salary boosts for nurses employed in kindergartens and nurseries have been made recently, the fundamental challenges endure, plunging the sector into a precarious situation
Gas Leak Emergency in Karnobat: People Seek Medical Assistance
A new report of a gas leak in Karnobat has sparked concern among residents and authorities, as emergency services rush to address the situation
EU Warns of Potential Bird Flu Pandemic
The European Food Safety Agency (EFSA) issued a stark warning regarding the looming threat of a large-scale bird flu pandemic, underscoring the potential consequences if the virus were to transition to humans and establish human-to-human transmission
Bulgaria Outpaces EU Average in Doctor Numbers, but Nurses Lag Behind
Bulgaria boasts a higher number of graduated and practicing doctors per capita compared to the European Union's average, according to an analysis commissioned by the Bulgarian Medical Union
